Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021427

Expand all

CYMBALTA (DULOXETINE HYDROCHLORIDE)
EQ 20MG BASE Marketing Status: Prescription

Active Ingredient: DULOXETINE HYDROCHLORIDE
Proprietary Name: CYMBALTA
Dosage Form; Route of Administration: CAPSULE, DELAYED REL PELLETS; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021427
Product Number: 001
Approval Date: Aug 3, 2004
Applicant Holder Full Name: ELI LILLY AND CO
Marketing Status:  Prescription
Patent and Exclusivity Information

CYMBALTA (DULOXETINE HYDROCHLORIDE)
EQ 30MG BASE Marketing Status: Prescription

Active Ingredient: DULOXETINE HYDROCHLORIDE
Proprietary Name: CYMBALTA
Dosage Form; Route of Administration: CAPSULE, DELAYED REL PELLETS; ORAL
Strength: EQ 30MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021427
Product Number: 002
Approval Date: Aug 3, 2004
Applicant Holder Full Name: ELI LILLY AND CO
Marketing Status:  Prescription
Patent and Exclusivity Information

CYMBALTA (DULOXETINE HYDROCHLORIDE)
EQ 60MG BASE Marketing Status: Prescription

Active Ingredient: DULOXETINE HYDROCHLORIDE
Proprietary Name: CYMBALTA
Dosage Form; Route of Administration: CAPSULE, DELAYED REL PELLETS; ORAL
Strength: EQ 60MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021427
Product Number: 004
Approval Date: Aug 3, 2004
Applicant Holder Full Name: ELI LILLY AND CO
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English